NASDAQ (usa) | 6715.56 | -12.11 | -0.18% | |
FTSE 100 (london) | 7487.96 | -5.12 | -0.07% | |
DAX (german) | 13465.51 | 235.94 | 1.78% | |
NIKKEI 225 (japan) | 22420.08 | 408.47 | 1.86% | |
Hang - Seng (hong kong) | 28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) | 3391.61 | 17.53 | 0.52% | |
KOSPI (korea) | 2556.47 | 33.04 | 1.31% | |
All Ordinaries (australia) | 6005.30 | 28.90 | 0.48% | |
BOVESPA (brazil) | 74092.76 | -215.73 | -0.29% |
Kezar Life Sciences Inc (NASDAQ: KZR)
KZR Technical Analysis
5
As on 9th Jun 2023 KZR STOCK Price closed @ 2.44 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 10.68 & Strong Sell for SHORT-TERM with Stoploss of 14.11 we also expect STOCK to react on Following IMPORTANT LEVELS. |
KZRSTOCK Price
Open | 2.51 | Change | Price | % |
High | 2.52 | 1 Day | -0.03 | -1.21 |
Low | 2.36 | 1 Week | -0.42 | -14.69 |
Close | 2.44 | 1 Month | -0.01 | -0.41 |
Volume | 1166259 | 1 Year | -12.17 | -83.30 |
52 Week High 18.33 | 52 Week Low 2.34 |
NASDAQ USA Most Active Stocks
TSLA | 244.40 | 4.06% |
TTOO | 0.07 | -12.50% |
SOFI | 8.18 | 0.74% |
FFIE | 0.33 | 6.45% |
PONO | 1.72 | 2.38% |
AMD | 124.92 | 3.20% |
IDEX | 0.06 | 0.00% |
NKLA | 0.70 | 14.75% |
AMZN | 123.43 | -0.66% |
AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
KZR Daily Charts |
KZR Intraday Charts |
Whats New @ Bazaartrend |
KZR Free Analysis |
|
KZR Important Levels Intraday
RESISTANCE | 2.75 |
RESISTANCE | 2.65 |
RESISTANCE | 2.59 |
RESISTANCE | 2.53 |
SUPPORT | 2.35 |
SUPPORT | 2.29 |
SUPPORT | 2.23 |
SUPPORT | 2.13 |
KZR Forecast May 2024
4th UP Forecast | 11.03 |
3rd UP Forecast | 8.28 |
2nd UP Forecast | 6.57 |
1st UP Forecast | 4.87 |
1st DOWN Forecast | 0.01 |
2nd DOWN Forecast | -1.69 |
3rd DOWN Forecast | -3.4 |
4th DOWN Forecast | -6.15 |
KZR Weekly Forecast
4th UP Forecast | 8.14 |
3rd UP Forecast | 6.31 |
2nd UP Forecast | 5.18 |
1st UP Forecast | 4.05 |
1st DOWN Forecast | 0.83 |
2nd DOWN Forecast | -0.30 |
3rd DOWN Forecast | -1.43 |
4th DOWN Forecast | -3.26 |
KZR Forecast2024
4th UP Forecast | 33.85 |
3rd UP Forecast | 23.78 |
2nd UP Forecast | 17.55 |
1st UP Forecast | 11.32 |
1st DOWN Forecast | -6.44 |
2nd DOWN Forecast | -12.67 |
3rd DOWN Forecast | -18.9 |
4th DOWN Forecast | -28.97 |
Kezar Life Sciences Inc ( NASDAQ USA Symbol : KZR )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
KZR Other Details
Segment | EQ | |
Market Capital | 382650848.00 | |
Sector | Healthcare | |
Industry | Biotechnology | |
Offical website | > echo $website ; ?> |
KZR Address
KZR Latest News
KZR Business Profile
Kezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in immune-mediated diseases and cancer in the United States. The company's lead product candidate is KZR-616, a selective immunoproteasome inhibitor that is in Phase 2 clinical trials for various indications, including lupus nephritis, dermatomyositis, and polymyositis; and Phase 1b clinical trials in systemic lupus erythematosus and lupus nephritis. Its preclinical products include KZR-261, a novel first-in-class protein secretion inhibitor for the treatment of KZR-261; and KZR-TBD for the treatment of oncology and autoimmunity. The company was founded in 2015 and is based in South San Francisco, California. Address: 4000 Shoreline Court, South San Francisco, CA, United States, 94080
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service